Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Whether you overindulged on a night out or had a good cry session the night before, waking up with puffy eyes is never ideal.

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...

The treatment procedures are required in the case of the severity of the condition. The patient then needs to go for a kidney ...

Our kidneys have a very specific and important role in keeping our body healthy. They filter waste, balance fluids, and ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...